16

Oct2015
In a recent update released on their website, the pan-Canadian Pharmaceutical Alliance (pCPA) announced two significant developments: Québec is now participating in the pCPA; and The Office of the pCPA (the Office) is now operational. In Fall 2014, the Provincial/Territorial Health Ministers announced intentions for Québec’s participation in the Federation’s Health Care ... Read More

06

Oct2015
Based on stakeholder feedback received in May 2015, CADTH has announced that in the limited instances where no Canadian patient group exists, individual patient and caregiver input will now be accepted for the CADTH Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) programs, effective immediately. Please note that for ... Read More

27

Jul2015
Proposal to Amend Ontario Regulation 201/96 under the Ontario Drug Benefit Act and Regulation 935 under the Drug Interchangeability and Dispensing Fee Act The Ministry of Health and Long-Term Care is proposing to reform the Ontario Drug Benefit (ODB) program in order to make it more efficient, effective and sustainable. Proposed amendments ... Read More

19

Jun2015
INESSS is offering an opportunity for in-person meetings to manufacturers who have filed a submission by the deadline for drugs to be listed on the February 2016 “Liste des médicaments". These meetings will be held between August 28 and September 11, 2015, inclusively. Meetings will cover the following: Discussion on clinical studies Discussion ... Read More

12

Jun2015
The Minister of Health and Social Services has authorized three updates to the List of Medications covered by the basic prescription drug insurance plan and the List of Medications – Institutions in 2016: February 1, June 1 and October 3, 2016. Updates to the lists of medications for multisource generic ... Read More

27

May2015
The BC Ministry of Health recently wrote to manufacturers to communicate updates to its drug review process and reimbursement submission requirements. Updates to the Drug Review Process include: The Drug Benefit Council (DBC) will now screen drug submissions under review by CDR to determine if a full DBC review is necessary. If ... Read More

27

May2015
The Ontario Public Drug Programs Division (OPDP) recently announced amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act. The amendments include the establishment of a pricing framework for certain generic products approved for listing on the Ontario Drug Benefit (ODB) Formulary/Comparative Drug Index on or after April ... Read More

26

May2015
PDCI Market Access’s International Trends Series provides the results of an online survey conducted by PDCI between March 19, 2015 and March 25, 2015. Participants were payer and industry stakeholders in both Europe and Canada. The current issue presents the perspectives of stakeholders on the biosimilar market.  Recent experience in Norway ... Read More

25

May2015
The Canadian Organization for Rare Disorders (CORD) announced Friday that it will help launch Canada's first ever Rare Disease Strategy on Monday, May 25th, at 10am in Ottawa on Parliament Hill. This Strategy was prepared by CORD further to extensive consultations over the past year with various stakeholders, with input from patients, ... Read More

19

May2015
PDCI Market Access’s International Trends Series provides the results of an online survey conducted by PDCI between March 19, 2015 and March 25, 2015. Participants were payer and industry stakeholders in both Europe and Canada.  The current issue presents the perspectives of both private and public payers, and industry representatives ... Read More